Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Ribaud P, Schwarzenberg L, et al.
Machover D, et al. Among authors: goldschmidt e.
Cancer Treat Rep. 1984 Jun;68(6):881-6.
Cancer Treat Rep. 1984.
PMID: 6587933